October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 06, 2025

Sarcopenia Prevalence Reported in Advanced Lung Disease, Study

Researchers evaluate sarcopenia definitions and tools in patients with lung disease.

Conexiant

October 03, 2025

Fruit Intake: Does It Alter PM2.5 Effect?

UK Biobank analysis examines diet quality and fruit intake in relation to PM2.5 lung effects.

Conexiant

October 03, 2025

From Agent Orange to PCBs: Lessons for Care

Air Force reviews cancer risk in missile crews; early analyses show no excess mortality, but exposures to PCBs and benzene prompt vigilance and targeted histories.

KFF Health News

September 30, 2025

Biomarker in Fibrotic Lung Disorders Explored in Study

SPARC, an extracellular matrix protein, is identified as prognostic marker in interstitial lung diseases, including unclassifiable cases

The Pathologist

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

September 19, 2025

Multibiomarker Score Signaled Incident ILD

Blood protein biomarkers improve prediction of rheumatoid arthritis–associated lung disease.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant